Accumulating evidence indicates that the high expression of Bcl-2 pro-survival protein positively correlates with the drug resistance;2 however, the effect of Bcl-2 siRNA on intrinsic tumor resistance to metallodrugs is rarely reported. Here, BCL2 is linked to neoplasm.